With over 25 years of experience, I've been at the forefront of transforming scientific breakthroughs into life-changing therapies. My expertise spans the complete drug development lifecycle, from pre-clinical and clinical R&D to manufacturing to commercialization, driving product launches, strategic growth, and organizational transformations. My role involves guiding research and investments, optimizing clinical development plans, navigating regulatory complexities, and executing effective marketing strategies. At Biogen, I revitalized the Alzheimer's business unit by developing a 15-year franchise strategy that integrated research, diagnostics, biomarkers, and partnerships to commercialization. I spearheaded the global launch of LEQEMBI®, the first DMT in its field. As Head of the Multiple Sclerosis Franchise, I pioneered an expansive Intercontinental Region spanning over 60 markets, achieving exponential growth through innovative access strategies and adept regulatory navigation.A seasoned leader with a proven track record of scaling multi-billion-dollar franchises, I thrive in navigating complex challenges. My strategic vision, ability to build winning teams, and forging strategic partnerships and alliances consistently deliver exceptional results.Driven by a passion for human progress, I am committed to building a healthier future. Let's talk about how my strategic vision and proven leadership can boost your organization's growth and create a lasting impact.